Diluted HEPS 39cps, a +208% y-y increase on -36cps (restated). Revenue growth -15.2% y-y. GPM improved by 280bps to 28.9%. OPM increased from 0.4% to 5.4%. Expenses well controlled with growth -15% y-y. Expense to sales remained flat at 23.6%. No Interim dividend declared. Gross debt down -15% y-y. First positive PAT from continuing operations for three years
